Parham Sendi, Peter Graber, Werner Zimmerli. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseAntibiotics, Antitubercular/therapeutic useArthroplasty, Replacement, Hip/adverse effectsHumansProsthesis-Related Infections/drug therapyProsthesis-Related Infections/microbiologyProsthesis-Related Infections/prevention & controlRifampin/therapeutic useRisk FactorsTreatment Outcome
Substances: See more » Antibiotics, AntitubercularRifampin
Year: 2008 PMID: 18634165
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717